News coverage about ITUS Corporation (NASDAQ:ITUS) has trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. ITUS Corporation earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the business services provider an impact score of 46.5527319891573 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
ITUS Corporation (ITUS) opened at 0.9009 on Friday. ITUS Corporation has a 12-month low of $0.71 and a 12-month high of $6.82. The stock’s 50 day moving average price is $0.93 and its 200 day moving average price is $2.65. The stock’s market cap is $13.62 million.
About ITUS Corporation
ITUS Corporation is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek cancer detection platform measures a patient’s immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that enter the blood stream.
Receive News & Ratings for ITUS Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ITUS Corporation and related companies with MarketBeat.com's FREE daily email newsletter.
